Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer.

Shinohara N, Maruyama S, Shimizu S, Nishioka K, Abe T, C-Hatanaka K, Oba K, Nonomura K, Shirato H.

J Radiat Res. 2013 Nov 1;54(6):1095-101. doi: 10.1093/jrr/rrt049. Epub 2013 May 9.

2.

Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up.

Merino T, San Francisco IF, Rojas PA, Bettoli P, Zúñiga A, Besa P.

BMC Cancer. 2013 Nov 8;13:530. doi: 10.1186/1471-2407-13-530.

3.

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):656-61. Epub 2007 May 23.

PMID:
17512127
4.

Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.

Crandley EF, Hegarty SE, Hyslop T, Wilson DD, Dicker AP, Showalter TN.

Cancer Med. 2014 Apr;3(2):397-405. doi: 10.1002/cam4.205. Epub 2014 Feb 12.

5.

Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy.

Yamamoto S, Masuda H, Urakami S, Fujii Y, Sakamoto K, Kozuka T, Oguchi M, Fukui I, Yonese J.

Urology. 2015 Feb;85(2):407-13. doi: 10.1016/j.urology.2014.09.046. Epub 2014 Oct 30.

PMID:
25623703
7.

Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.

Di Lorenzo G, Perdonà S, De Placido S, D'Armiento M, Gallo A, Damiano R, Pingitore D, Gallo L, De Sio M, Autorino R.

J Urol. 2005 Dec;174(6):2197-203.

PMID:
16280763
8.

Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.

Moinpour CM, Hayden KA, Unger JM, Thompson IM Jr, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S, Crawford ED, Southwest Oncology Group.

J Clin Oncol. 2008 Jan 1;26(1):112-20. doi: 10.1200/JCO.2006.10.4505.

9.

Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.

McCammon KA, Kolm P, Main B, Schellhammer PF.

Urology. 1999 Sep;54(3):509-16.

PMID:
10475363
10.
11.

Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.

Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y.

Jpn J Clin Oncol. 2006 Apr;36(4):224-30. Epub 2006 Mar 14.

12.

Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

Kitamura K, Shirato H, Shinohara N, Harabayashi T, Onimaru R, Fujita K, Shimizu S, Nonomura K, Koyanagi T, Miyasaka K.

Cancer J. 2003 Jul-Aug;9(4):268-76.

PMID:
12967137
13.

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups.

Azelie C, Gauthier M, Mirjolet C, Cormier L, Martin E, Peignaux-Casasnovas K, Truc G, Chamois J, Maingon P, Créhange G.

Radiat Oncol. 2012 Sep 17;7:158. doi: 10.1186/1748-717X-7-158.

14.

A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer.

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD.

BJU Int. 2013 Feb;111(2):221-32. doi: 10.1111/j.1464-410X.2012.11198.x. Epub 2012 Jun 6.

15.
16.

Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.

Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, Numata I, Satoh M, Saito S, Koinuma N, Arai Y.

Int J Urol. 2004 Aug;11(8):619-27.

17.

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.

Forsythe K, Blacksburg S, Stone N, Stock RG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.

PMID:
22099032
18.
19.

Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.

Fletcher SG, Mills SE, Smolkin ME, Theodorescu D.

Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1092-9. Epub 2006 Sep 11.

PMID:
16965872
20.

Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Eur Urol. 2011 Dec;60(6):1142-8. doi: 10.1016/j.eururo.2011.08.006. Epub 2011 Aug 12.

PMID:
21855208
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk